Dihydrodiol-Ibrutinib -d5 is the deuterium labeled Dihydrodiol-Ibrutinib ( HY-100659 ). Dihydrodiol-Ibrutinib is a dihydrodiol active metabolite of Ibrutinib ( HY-10997 ), has inhibitory activity towards BTK approximately 15 times lower than that of ibrutinib.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Others | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Btk | Products > Signaling Pathways > Isotope-Labeled Compounds
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.